Enlivex Therapeutics (ENLV) Stock Chart & Stock Price History $0.96 +0.03 (+2.75%) Closing price 05/30/2025 03:59 PM EasternExtended Trading$0.94 -0.02 (-2.43%) As of 05/30/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enlivex Therapeutics Stock Price Performance The Enlivex Therapeutics (ENLV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 29.16%, with a year-to-date return of -17.66%. In the past month, the stock has decreased 8.25%, reflecting recent market activity. As of the latest close, Enlivex Therapeutics traded at $0.96 with a market cap of $22.79 million and volume of 6,770 shares. Five years ago, the stock traded at $5.39, representing a 82.13% decrease over that period. At the time, it had a market cap of $69.70 million and a volume of 26,582 shares. Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.52%1 Month Performance-8.25%3 Month Performance-19.72%Year-To-Date Performance-17.66%1 Year Performance-29.16%5 Year Performance-82.13% ENLV Stock Chart for Sunday, June, 1, 2025 ENLV Chart by TradingView Enlivex Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/30/2025$0.95$0.96+1.84%$0.97$0.936,770 shs$22.79 million05/29/2025$0.96$0.95-0.94%$0.98$0.9248,328 shs$22.37 million05/28/2025$0.95$0.96+0.63%$1.02$0.9497,239 shs$22.59 million05/27/2025$0.98$0.95-2.67%$1.03$0.9268,361 shs$22.45 million05/26/2025$0.98$0.98$0.98$0.9616,709 shs$23.06 million05/23/2025$0.96$0.98+1.34%$0.98$0.9616,709 shs$23.06 million05/22/2025$0.98$0.96-1.78%$1.00$0.9619,052 shs$22.76 million05/21/2025$0.99$0.98-1.06%$0.99$0.9650,686 shs$23.17 million05/20/2025$0.99$0.99$1.03$0.9554,353 shs$23.41 million05/19/2025$1.00$0.99-1.00%$1.00$0.9877,748 shs$23.41 million Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/16/2025$1.03$1.00-2.91%$1.04$1.0056,570 shs$23.65 million05/15/2025$1.03$1.03$1.04$1.0112,892 shs$24.36 million05/14/2025$1.00$1.03+3.00%$1.05$0.98108,373 shs$24.36 million05/13/2025$1.00$1.00-0.30%$1.03$0.9783,572 shs$23.65 million05/12/2025$1.02$1.00-1.67%$1.05$0.9938,358 shs$23.72 million05/09/2025$1.04$1.02-1.92%$1.09$1.0139,279 shs$24.12 million05/08/2025$1.05$1.04-0.95%$1.06$1.0435,353 shs$22.26 million05/07/2025$1.10$1.05-4.55%$1.11$1.0458,464 shs$22.48 million05/06/2025$1.04$1.10+5.77%$1.15$1.04106,645 shs$23.55 million05/05/2025$1.04$1.04$1.06$1.0359,894 shs$22.26 million05/02/2025$1.05$1.04-0.95%$1.07$1.0337,161 shs$22.26 million05/01/2025$1.02$1.05+2.94%$1.07$1.0137,485 shs$22.48 million04/30/2025$1.05$1.02-2.45%$1.05$1.0086,358 shs$21.83 million Related Companies CRDL Stock Chart TVRD Stock Chart CRBP Stock Chart IVVD Stock Chart CABA Stock Chart ENTX Stock Chart IMUX Stock Chart CHRS Stock Chart ORMP Stock Chart XBIT Stock Chart Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENLV) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enlivex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
